Page last updated: 2024-08-23

oltipraz and Breast Neoplasms

oltipraz has been researched along with Breast Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benson, AB; Dolan, ME; French, S; Mobarhan, S; Olopade, OI; Rademaker, A; Ratain, MJ; Stucky-Marshall, L1
Ali, IU; Herbert, BS; Kopelovich, L; Passons, CM; Shay, JW; Wright, AC; Wright, WE1
Freeman, JW; Gupta, RC; Smith, WA1

Trials

1 trial(s) available for oltipraz and Breast Neoplasms

ArticleYear
Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patients.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:10

    Topics: Anticarcinogenic Agents; Biopsy; Breast Neoplasms; Colonic Polyps; Dose-Response Relationship, Drug; Female; Glutathione; Glutathione Transferase; Hot Temperature; Humans; Lymphocytes; Male; Pyrazines; Rectum; Thiones; Thiophenes; Time Factors

2000

Other Studies

2 other study(ies) available for oltipraz and Breast Neoplasms

ArticleYear
Effects of chemopreventive and antitelomerase agents on the spontaneous immortalization of breast epithelial cells.
    Journal of the National Cancer Institute, 2001, Jan-03, Volume: 93, Issue:1

    Topics: Antineoplastic Agents; Breast; Breast Neoplasms; Cell Division; Cell Transformation, Neoplastic; Cells, Cultured; Disease Progression; DNA, Complementary; Eflornithine; Enzyme Activation; Enzyme Inhibitors; Epithelial Cells; Female; Humans; Li-Fraumeni Syndrome; Oligodeoxyribonucleotides, Antisense; Point Mutation; Pyrazines; Reverse Transcriptase Inhibitors; Tamoxifen; Telomerase; Thiones; Thiophenes; Transformation, Genetic; Tretinoin

2001
Effect of chemopreventive agents on DNA adduction induced by the potent mammary carcinogen dibenzo[a,l]pyrene in the human breast cells MCF-7.
    Mutation research, 2001, Sep-01, Volume: 480-481

    Topics: Anticarcinogenic Agents; Antimutagenic Agents; Antineoplastic Agents; Benzopyrenes; Breast; Breast Neoplasms; Carcinogens; Cell Line; Chemoprevention; Chlorophyllides; DNA Adducts; Dose-Response Relationship, Drug; Female; Humans; Pyrazines; Thiones; Thiophenes

2001